MBS-303 - Drug Targets, Indications, Patents - Synapse - Patsnap
mbs303mbs303cd3cd20t MBS303MBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trials